Cited by 2,020Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorMental Health and Psychiatry

The DOI matches its Crossref record; 398 of the 399 references it cites were found in a registry or an index.

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P J, Weinberger, D R·2005·Molecular Psychiatry

DOI 10.1038/sj.mp.4001558

Open this paper in CoChat — free account

Abstract

This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001558

Cites

398 of 398 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citation
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788

Show all 399 references

Research works printed but not linked: 4

Grossman MH, Littrel JB, Weinstein R, Szumlanski C, Weinshilboum R . Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc 1992; 18: 70.
Straub RE, Egan MF, Hashimoto R, Matsumoto M, Weickert CS, Goldberg T et al. The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): analysis of haplotypes, intermediate phenotypes, and alternative transcripts. Biol Psychiatry 2003; 53: 167S.
Callicott JH, Pezeawas L, Egan MF, Hariri AR, Mattay VS, Goldberg TE et al. Genetic variationVariation in DISC-1 affects hippocampal structure and function associated with increased risk for schizophrenia and with normal hippocampal structure and function. (in review).
Toro CT, Kasher PR, Deakin JFW . Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains [Abstract]. Schizophr Res 2004; 67(Suppl): 125.

Sorted by citations

Items 401–500 of 1,003

DISC1 and neurocognitive function in schizophrenia
Burdick, K. E., Hodgkinson, C. A., Szeszko, P. R., Lencz, T., Ekholm, J. M., Kane, J. M., Goldman, D. A., & Malhotra, A. K. (2005) · Neuroreport · doi:10.1097/01.wnr.0000175248.25535.f6 · Cited by 105
DISC1 Regulates Neurotrophin-Induced Axon Elongation via Interaction with Grb2
Shinoda, T., Taya, S., Tsuboi, D., Hikita, T., Matsuzawa, R., Kuroda, S., Iwamatsu, A., & Kaibuchi, K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3825-06.2007 · Cited by 104
A form of DISC1 enriched in nucleus: Altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse
Sawamura, N., Sawamura-Yamamoto, T., Ozeki, Y., Ross, C. A., & Sawa, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406543102 · Cited by 105
Importance of Animal Models in Schizophrenia Research
van den Buuse, M., Garner, B., Gogos, A., & Kusljic, S. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01626.x · Cited by 105
Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes
Brown, J. A., Ramikie, T. S., Schmidt, M. J., Báldi, R., Garbett, K. A., Everheart, M., Warren, L. E., Gellért, L., Horváth, S., Patel, S., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.192 · Cited by 108
Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia
Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109625108 · Cited by 103
Genes and Schizophrenia: Beyond Schizophrenia: The Role of DISC1 in Major Mental Illness
Hennah, W., Thomson, P. A., Peltonen, L., & Porteous, D. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj079 · Cited by 103
Cellular Basis of Reduced Cortical Reelin Expression in Schizophrenia
Eastwood, S. L., & Harrison, P. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.540 · Cited by 104
Self-citation
Application of Electroencephalography to the Study of Cognitive and Brain Functions in Schizophrenia
van der Stelt, O., & Belger, A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm016 · Cited by 105
Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study
Haas, M., Eerdekens, M., Kushner, S. F., Singer, J., Augustyns, I., Quiroz, J. A., Pandina, G., & Kusumakar, V. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046177 · Cited by 103
IQ and Schizophrenia in a Swedish National Sample: Their Causal Relationship and the Interaction of IQ With Genetic Risk
Kendler, K. S., Ohlsson, H., Sundquist, J., & Sundquist, K. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14040516 · Cited by 102
Interaction between FEZ1 and DISC1 in Regulation of Neuronal Development and Risk for Schizophrenia
Kang, E., Burdick, K. E., Kim, J. Y., Duan, X., Guo, J. U., Sailor, K. A., Jung, D.-E., Ganesan, S., Choi, S., Pradhan, D. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.032 · Cited by 104
Schizophrenia: who is at risk? Who is a case?
Verdoux, H., & Cougnard‐Grégoire, A. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000201496.23259.85 · Cited by 102
Positive Allosteric Modulation of Metabotropic Glutamate 5 (mGlu5) Receptors Reverses N-Methyl-D-Aspartate Antagonist-Induced Alteration of Neuronal Firing in Prefrontal Cortex
Lecourtier, L., Homayoun, H., Tamagnan, G. D., & Moghaddam, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.003 · Cited by 103
Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia
Tkachev, D., Mimmack, M. L., Huffaker, S. J., Ryan, M., & Bahn, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007334 · Cited by 101
Multi-Target Approach for Drug Discovery against Schizophrenia
Kondej, M., Stępnicki, P., & Kaczor, A. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103105 · Cited by 106
Making the Case for a Candidate Vulnerability Gene in Schizophrenia: Convergent Evidence for Regulator of G-Protein Signaling 4 (RGS4)
Levitt, P. R., Ebert, P. J., Mirnics, K., Nimgaonkar, V. L., & Lewis, D. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.028 · Cited by 100
Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families
Wedenoja, J., Loukola, A., Tuulio‐Henriksson, A., Paunio, T., Ekelund, J., Silander, K., Varilo, T., Heikkila, K. V., Suvisaari, J., Partonen, T., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002047 · Cited by 102
DISC1 in Schizophrenia: Genetic Mouse Models and Human Genomic Imaging
Johnstone, M., Thomson, P. A., Hall, J., McIntosh, A. M., Lawrie, S. M., & Porteous, D. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq135 · Cited by 104
The role of prefrontal catecholamines in attention and working memory
Clark, K., & Noudoost, B. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00033 · Cited by 113
Loss of Glial Glutamate and Aspartate Transporter (Excitatory Amino Acid Transporter 1) Causes Locomotor Hyperactivity and Exaggerated Responses to Psychotomimetics: Rescue by Haloperidol and Metabotropic Glutamate 2/3 Agonist
Karlsson, R., Tanaka, K., Heilig, M. A., & Holmes, A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.001 · Cited by 100
Dysbindin Modulates Prefrontal Cortical Glutamatergic Circuits and Working Memory Function in Mice
Jentsch, J. D., Trantham‐Davidson, H., Jairl, C., Tinsley, M. R., Cannon, T. D., & Lavı́n, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.90 · Cited by 100
Epigenetic and transgenerational mechanisms in infection-mediated neurodevelopmental disorders
Weber‐Stadlbauer, U. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.78 · Cited by 98
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia
Meyer, U., & Feldon, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1504-9 · Cited by 103
Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers
Mexal, S., Berger, R., Logel, J., Ross, R. G., Freedman, R., & Leonard, S. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9233-4 · Cited by 101
Pharmacogenomics and antidepressant drugs
Binder, E. B., & Holsboer, F. (2006) · Annals of Medicine · doi:10.1080/07853890600551045 · Cited by 103
Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer?
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002145 · Cited by 99
Self-citation
Allelic Variation in RGS4 Impacts Functional and Structural Connectivity in the Human Brain
Buckholtz, J. W., Meyer‐Lindenberg, A., Honea, R. A., Straub, R. E., Pezawas, L., Egan, M. F., Vakkalanka, R., Kolachana, B. S., Verchinski, B. A., Sust, S., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5112-06.2007 · Cited by 104
Self-citation
From Animal Models to Model Animals
Insel, T. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.001 · Cited by 98
The Dopamine Hypothesis of Schizophrenia: An Historical and Philosophical Analysis
Kendler, K. S., & Schaffner, K. F. (2011) · Philosophy, psychiatry & psychology · doi:10.1353/ppp.2011.0005 · Cited by 99
Dysconnectivity Within the Default Mode in First-Episode Schizophrenia: A Stochastic Dynamic Causal Modeling Study With Functional Magnetic Resonance Imaging
de Bastos-Leite, A. J., Ridgway, G. R., Silveira, C., Norton, A., Reis, S., & Friston, K. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu080 · Cited by 101
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Balu, D. T., Carlson, G. C., Talbot, K., Kazi, H., Hill‐Smith, T. E., Easton, R. M., Birnbaum, M. J., & Lucki, I. (2010) · Hippocampus · doi:10.1002/hipo.20887 · Cited by 101
Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms
Lieshout, R. J. V., & Voruganti, L. P. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0837 · Cited by 100
Common Proteomic Changes in the Hippocampus in Schizophrenia and Bipolar Disorder and Particular Evidence for Involvement of Cornu Ammonis Regions 2 and 3
Föcking, M., Dicker, P., English, J. A., Schubert, K. O., Dunn, M. J., & Cotter, D. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.43 · Cited by 90
Advances in endophenotyping schizophrenia
BRAFF, D. L., Greenwood, T. A., Swerdlow, N. R., Light, G. A., & Schork, N. J. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00140.x · Cited by 97
How antipsychotics work—From receptors to reality
Kapur, S., Agid, O., Mizrahi, R., & Li, M. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.003 · Cited by 102
D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
Sacchi, S., Rosini, E., Pollegioni, L., & Molla, G. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319140002 · Cited by 98
Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation
Lévesque, D., & Rouillard, C. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.11.006 · Cited by 98
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia
Hjelm, B. E., Rollins, B. L., Mamdani, F., Lauterborn, J. C., Kirov, G., LYNCH, G. S., Gall, C. M., Sequeira, A., & Vawter, M. P. (2015) · Complex Psychiatry · doi:10.1159/000441252 · Cited by 98
Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia
Mahadik, S. P., Pillai, A., Joshi, S., & Foster, A. E. (2006) · International Review of Psychiatry · doi:10.1080/09540260600581993 · Cited by 98
Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
Reale, M., Costantini, E., & Greig, N. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.536257 · Cited by 111
Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression
Neff, C. D., Abkevich, V., Packer, J. C. L., Chen, Y., Potter, J., Riley, R., Davenport, C., Warren, J., Jammulapati, S., Bhathena, A., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.8 · Cited by 97
Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia
Stephens, S. H., Logel, J., Barton, A., Franks, A. L., Finlay-Schultz, J., Short, M., Dickenson, J., James, B., Fingerlin, T. E., Wagner, B. D., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.017 · Cited by 97
Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96
Reduced protein synthesis in schizophrenia patient-derived olfactory cells
English, J. A., Fan, Y., Föcking, M., Lopez, L. M., Hryniewiecka, M., Wynne, K. J., Dicker, P., Matigian, N., Cagney, G., Mackay‐Sim, A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.119 · Cited by 97
The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline results
Castro‐Fornieles, J., Parellada, M., González-Pinto, A. M., Moreno, D. M., Graell, M., Baeza, I., Otero, S., Soutullo, C. A., Crespo‐Facorro, B., Ruíz-Sancho, A., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.12.004 · Cited by 96
Astrocyte and Glutamate Markers in the Superficial, Deep, and White Matter Layers of the Anterior Cingulate Gyrus in Schizophrenia
Katsel, P., Byne, W. M., Roussos, P., Tan, W., Siever, L. J., & Haroutunian, V. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.252 · Cited by 96
Differential Expression of Metabotropic Glutamate Receptors 2 and 3 in Schizophrenia: A Mechanism for Antipsychotic Drug Action?
Ghose, S., Gleason, K., Potts, B. W., Lewis‐Amezcua, K., & Tamminga, C. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08091445 · Cited by 96
Perineuronal nets and schizophrenia: The importance of neuronal coatings
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.018 · Cited by 95
Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance
Bertolino, A., Taurisano, P., Pisciotta, N., Blasi, G., Fazio, L., Romano, R., Gelao, B., Bianco, L. L., Lozupone, M., Giorgio, A. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009348 · Cited by 98
Effects of aCACNA1Cgenotype on attention networks in healthy individuals
Thimm, M., Kircher, T. T. J., Kellermann, T., Markov, V., Krach, S., Jansen, A., Zerres, K., Eggermann, T., Stöcker, T., Shah, N. J., et al. (2010) · Psychological Medicine · doi:10.1017/s0033291710002217 · Cited by 96
Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations
Feng, J., Sun, G., Jin, Y., Noltner, K., Li, W., Buzin, C. H., Longmate, J., Heston, L. L., Rossi, J. J., & Sommer, S. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006121 · Cited by 95
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 98
What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit
Barkus, C., Sanderson, D. J., Rawlins, J. N. P., Walton, M. E., Harrison, P. J., & Bannerman, D. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.91 · Cited by 92
Self-citation
Modification of Cognitive Performance in Schizophrenia by Complexin 2 Gene Polymorphisms
Begemann, M., Grube, S., Papiol, S., Malzahn, D., Krampe, H., Ribbe, K., Friedrichs, H., Radyushkin, K., El-Kordi, A., Benseler, F., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.107 · Cited by 94
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Fišar, Z. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110626 · Cited by 103
The Adhesion Molecule CHL1 Regulates Uncoating of Clathrin-Coated Synaptic Vesicles
Leshchyns’ka, I., Sytnyk, V., Richter, M., Andreyeva, A., Puchkov, D., & Schachner, M. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.020 · Cited by 94
Association between Psychotic Symptoms and Cortical Thickness Reduction across the Schizophrenia Spectrum
Oertel‐Knöchel, V., Knöchel, C., Rotarska-Jagiela, A., Reinke, B., Prvulovic, D., Haenschel, C., Hampel, H. J., & Linden, D. E. J. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr380 · Cited by 97
Role of DISC1 in neural development and schizophrenia
Mackie, S., Millar, J. K., & Porteous, D. J. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.007 · Cited by 94
Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile
Shayegan, D. K., & Stahl, S. M. (2004) · CNS Spectrums · doi:10.1017/s1092852900025086 · Cited by 94
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Snyder, M. A., & Gao, W. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.010 · Cited by 97
MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia
Xu, Y. J., Li, F., Zhang, B., Zhang, K., Zhang, F., Huang, X., Sun, N., Ren, Y., Sui, M., & Liu, P. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1070 · Cited by 94
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications
Gaspar, P. A., Bustamante, M. L., Hernán Silva, I., & Aboitiz, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06325.x · Cited by 91
The myelin-pathogenesis puzzle in schizophrenia: a literature review
Karoutzou, G., Emrich, H. M., & Dietrich, D. E. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002096 · Cited by 95
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers
Mexal, S., Frank, M., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., & Leonard, S. S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.06.006 · Cited by 93
Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?
Rolland, B., Jardri, R., Amad, A., Thomas, P., Cottencin, O., & Bordet, R. (2014) · BioMed Research International · doi:10.1155/2014/307106 · Cited by 103
Brain vs Behavior: An Effect Size Comparison of Neuroimaging and Cognitive Studies of Genetic Risk for Schizophrenia
Rose, E. J., & Donohoe, G. J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs056 · Cited by 92
Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights
Zamanpoor, M. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000245 · Cited by 96
Metabotropic glutamate receptor 7: At the interface of cognition and emotion
O’Connor, R. M., Finger, B. C., Flor, P. J., & Cryan, J. F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.059 · Cited by 97
A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth
Hattori, T., Baba, K., Matsuzaki, S., Honda, A., Miyoshi, K., Inoue, K., Taniguchi, M., Hashimoto, H., Shintani, N., Baba, A., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001945 · Cited by 92
Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons
Critchlow, H., Maycox, P. R., Skepper, J. N., & Krylova, O. Y. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.05.007 · Cited by 93
Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
Schubert, K. O., Föcking, M., Prehn, J. H. M., & Cotter, D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.123 · Cited by 91
DNA methylation in schizophrenia: progress and challenges of epigenetic studies
Nishioka, M., Bundo, M., Kasai, K., & Iwamoto, K. (2012) · Genome Medicine · doi:10.1186/gm397 · Cited by 94
DTNBP1 (Dysbindin) Gene Variants Modulate Prefrontal Brain Function in Healthy Individuals
Fallgatter, A. J., Herrmann, M. J., Hohoff, C., Ehlis, A., Jarczok, T. A., Freitag, C. M., & Deckert, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301003 · Cited by 91
Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3
Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. (2010) · Synapse · doi:10.1002/syn.20839 · Cited by 92
Tonic Activation of GluN2C/GluN2D-Containing NMDA Receptors by Ambient Glutamate Facilitates Cortical Interneuron Maturation
Hanson, E., Armbruster, M., Lau, L. A., Sommer, M., Klaft, Z., Swanger, S. A., Traynelis, S. F., Moss, S. J., Noubary, F., Chadchankar, J., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1392-18.2019 · Cited by 89
Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase
Babovic, D., O’Tuathaigh, C. M. P., O'Connor, A. M., O'Sullivan, G. J., Tighe, O., Croke, D. T., Karayiorgou, M., Gogos, J. A., Cotter, D., & Waddington, J. L. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.006 · Cited by 90
Genetic Neuropathology of Schizophrenia: New Approaches to an Old Question and New Uses for Postmortem Human Brains
Kleinman, J. E., Law, A. J., Lipska, B. K., Hyde, T. M., Ellis, J. K., Harrison, P. J., & Weinberger, D. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.032 · Cited by 89
Self-citation
White matter and cognitive function in schizophrenia
Dwork, A. J., Mancevski, B., & Rosoklija, G. B. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007638 · Cited by 92
Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
Knuesel, I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.002 · Cited by 89
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: Implications for schizophrenia
Pershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 92
Impaired Hippocampal Neuroligin-2 Function by Chronic Stress or Synthetic Peptide Treatment is Linked to Social Deficits and Increased Aggression
van der Kooij, M. A., Fantin, M., Kraev, I., Korshunova, I., Grosse, J., Zanoletti, O., Guirado, R., García-Mompó, C., Nácher, J., Stewart, M. G., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.315 · Cited by 92
Activation of Glycogen Synthase Kinase-3β Is Required for Hyperdopamine and D 2 Receptor-Mediated Inhibition of Synaptic NMDA Receptor Function in the Rat Prefrontal Cortex
Li, Y.-C., Xi, D., Roman, J., Huang, Y.-Q., & Gao, W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3336-09.2009 · Cited by 93
Association of 5′ end neuregulin-1 ( NRG1 ) gene variation with subcortical medial frontal microstructure in humans
Winterer, G., Konrad, A., Vučurević, G., Musso, F., Stoeter, P., & Dahmen, N. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.041 · Cited by 88
Tau's role in the developing brain: implications for intellectual disability
Sapir, T., Frotscher, M., Levy, T., Mandelkow, E., & Reiner, O. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr603 · Cited by 93
Metabotropic Glutamate Receptors as Therapeutic Targets for Schizophrenia
Vinson, P., & Conn, P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.005 · Cited by 95
Schizophrenia Genomics: Convergence on Synaptic Development, Adult Synaptic Plasticity, or Both?
Hall, J., & Bray, N. J. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.018 · Cited by 90
Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous ‘knockout’ of the schizophrenia risk gene neuregulin-1
O’Tuathaigh, C. M. P., O'Connor, A.-M., O'Sullivan, G. J., Lai, D., Harvey, R. P., Croke, D. T., & Waddington, J. L. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.018 · Cited by 88
Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation
Ito, H., Morishita, R., Shinoda, T., Iwamoto, I., Sudo, K., Okamoto, K., & Nagata, K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.69 · Cited by 88
Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis
Trzesniak, C. M. F., de Oliveira, I. R., Kempton, M. J., Almeida, A. G.-D., Chagas, M. H. N., Ferrari, M. C. F., Filho, A. S., Zuardi, A. W., Prado, D. A., Busatto, G. F., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.016 · Cited by 89
Microtubule Stabilizer Ameliorates Synaptic Function and Behavior in a Mouse Model for Schizophrenia
Andrieux, A., Salin, P. A., Schweitzer, A., Bégou, M., Pachoud, B., Brun, P., Gory‐Fauré, S., Kujala, P., Suaud‐Chagny, M., Höfle, G., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.048 · Cited by 94
Opportunities and Challenges of Psychiatric Drug Discovery: Roles for Scientists in Academic, Industry, and Government Settings
Conn, P. J., & Roth, B. L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301638 · Cited by 87
One-carbon metabolism and schizophrenia: current challenges and future directions
Krebs, M., Bellon, A., Mainguy, G., Jay, T. M., & Frieling, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.001 · Cited by 89
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs
Wierońska, J. M., & Pilc, A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.02.019 · Cited by 90
Structural Cerebral Variations as Useful Endophenotypes in Schizophrenia: Do They Help Construct "Extended Endophenotypes"?
Prasad, K. M. R., & Keshavan, M. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn017 · Cited by 85
Gene Expression Profiling in Schizophrenia and Related Mental Disorders
Iwamoto, K., & Kato, T. (2006) · The Neuroscientist · doi:10.1177/1073858406287536 · Cited by 88
Genomic imprinting in the development and evolution of psychotic spectrum conditions
Crespi, B. J. (2008) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2008.00050.x · Cited by 87
Disconnection and Cognitive Dysmetria in Schizophrenia
Friston, K. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.429 · Cited by 86
Decreased mRNA Expression of Netrin-G1 and Netrin-G2 in the Temporal Lobe in Schizophrenia and Bipolar Disorder
Eastwood, S. L., & Harrison, P. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301457 · Cited by 82
Self-citation
The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia
Lawford, B. R., Young, R. M., Swagell, C. D., Barnes, M., Burton, S. C., Ward, W. K., Heslop, K., Shadforth, S., van Daal, A., & Morris, C. P. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.020 · Cited by 85

Authors: Harrison, P. J., & Weinberger, D. R.
Affiliations: Warneford Hospital (GB)
National Institutes of Health (US)
ORCID: Harrison, P J
Weinberger, D R
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2004-07-20
Volume: 10
Issue: 1
Pages: 40-68
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/sj.mp.4001558
OpenAlex: W2071090720
Cited by: 2,020
References: 399
Citations by year: 2026: 10 · 2025: 20 · 2024: 22 · 2023: 38 · 2022: 38 · 2021: 34 · 2020: 34 · 2019: 42 · 2018: 52 · 2017: 58 · 2016: 66 · 2015: 88 · 2014: 102 · 2013: 92 · 2012: 129
FWCI: 22.22
Type: journal article
Language: en
Update notices: erratum (2005-03-29)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Molecular Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia, schizophrenia genetics, susceptibility genes, gene expression, synaptic plasticity, cortical microcircuitry, NMDA receptor, glutamatergic neurotransmission, dopamine signalling, GABA signalling, neuregulin, dysbindin, catechol-O-methyltransferase, DISC1, RGS4, GRM3, G72, hippocampus, dorsolateral prefrontal cortex, dorsal thalamus, brain connectivity
MeSH terms: Dysbindin, Brain, Carrier Proteins, Catechol O-Methyltransferase, Gene Expression Regulation, Humans, Schizophrenia, Genetic Predisposition to Disease, Neuregulin-1, Dystrophin-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks